Perspective Therapeutics (CATX) Interest Coverage Ratio (2016 - 2026)
Perspective Therapeutics' Interest Coverage Ratio history spans 11 years, with the latest figure at 269.34 for Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 57.91% to 269.34 in Q1 2026 year-over-year; TTM through Mar 2026 was 339.98, a 49.88% increase, with the full-year FY2025 number at 302.03, up 84.05% from a year prior.
- Interest Coverage Ratio hit 269.34 in Q1 2026 for Perspective Therapeutics, up from 622.38 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for CATX hit a ceiling of 616.22 in Q4 2024 and a floor of 696.43 in Q3 2023.
- Historically, Interest Coverage Ratio has averaged 347.36 across 4 years, with a median of 428.63 in 2025.
- Biggest five-year swings in Interest Coverage Ratio: skyrocketed 226.66% in 2024 and later crashed 201.0% in 2025.
- Tracing CATX's Interest Coverage Ratio over 4 years: stood at 486.5 in 2023, then skyrocketed by 226.66% to 616.22 in 2024, then crashed by 201.0% to 622.38 in 2025, then surged by 56.72% to 269.34 in 2026.
- Business Quant data shows Interest Coverage Ratio for CATX at 269.34 in Q1 2026, 622.38 in Q4 2025, and 428.63 in Q3 2025.